Примери за използване на Professionals who are expected на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The MAH shall ensure that all healthcare professionals who are expected to prescribe or use Provenge are provided with the following items.
The MAH shall ensure that, following discussion and agreement with the National Competent Authorities in each Member State where ADASUVE is marketed, at launch andafter launch, all healthcare professionals who are expected to use ADASUVE are provided with an information pack containing the following items.
The company will ensure that all healthcare professionals who are expected to use the medicine are provided with information on how to enter their patients in the registry.
The Marketing Authorisation Holder(MAH) should ensure that,at launch, all Healthcare Professionals who are expected to prescribe Cinryze are provided with an Educational pack.
The company that markets Jetrea must ensure that all healthcare professionals who are expected to use Jetrea receive the summary of product characteristics for the medicine as well as an information pack to be given to patients.
The MAH shall ensure that in each Member State where Kanuma is marketed,all healthcare professionals who are expected to use Kanuma have access to the educational material.
The company that makes Adasuve must ensure that all healthcare professionals who are expected to use Adasuve receive an information pack containing key information on how to use the medicine as well as important safety information.
The MAH shall ensure that in each Member State where Mysimba is marketed,all healthcare professionals who are expected to prescribe Mysimba are provided with a prescriber guide.
The company that markets Ruconest will ensure that healthcare professionals who are expected to prescribe Ruconest are provided with an educational pack containing information on the proper use of the medicine and warnings about the risk of allergy.
The MAH shall ensure that in each Member State where Kevzara is marketed,all healthcare professionals who are expected to prescribe Kevzara have access to the patient alert card.
The company that markets Optimark will ensure that all healthcare professionals who are expected to use this medicine are informed that it should not be used in children below 2 years as the effect of the medicine in this age group, such as its effect on immature kidneys, has not been studied.
The MAH shall ensure that, in each Member State where Amglidia is marketed,all healthcare professionals who are expected to prescribe Amglidia, have access to the following educational guide.
In addition, the company that markets Aubagio must ensure that all healthcare professionals who are expected to use Aubagio receive an information pack containing important safety information, including the tests and monitoring that should be carried out in patients before and after starting treatment.
The MAH shall ensure that in each Member State where Spherox is marketed, all surgeons andother health professionals who are expected to prescribe and administer the product have access to the educational materials including.
The MAH shall ensure that in each Member State where Axumin is marketed,all Healthcare professionals who are expected to use Axumin have access to self-training educational material in order to reduce the risk of PET imaging interpretation errors.
The MAH shall ensure that, following discussions andagreement with the National Competent Authorities in each Member State where Intuniv is launched all healthcare professionals who are expected to prescribe Intuniv are informed through an information letter on having access to/ are provided with the following items.
The MAH shall ensure that in each Member State where Nerlynx is marketed,all healthcare professionals who are expected to prescribe/dispense Nerlynx, as well as all patients/carers who are expected to use Nerlynx, have access to/are provided with the following educational package.
The MAH shall ensure that in each Member State where Solymbic is marketed,all healthcare professionals who are expected to prescribe Solymbic have are provided with the following educational package.
The MAH shall ensure that, in each Member State where Suliqua is marketed,all healthcare professionals who are expected to prescribe, dispense and patients who are expected to use Suliqua, have access to/are provided with the following educational package.
The MAH shall ensure that, following discussions andagreement with the National Competent Authorities in each Member State where IONSYS is launched all healthcare professionals who are expected to prescribe, dispense or administer IONSYS are informed through an information letter on having access to/ are provided with the following items.
The Marketing Authorisation Holder(MAH) should ensure that,at launch, all Healthcare Professionals who are expected to prescribe/ use ReFacto AF, all laboratories that are expected to monitor patients receiving ReFacto AF and all EU Haemophiliac patients associations are provided with Educational packs.
The MAH should ensure that, at launch andthereafter, all Healthcare Professionals who are expected to use and/or prescribe XALKORI are provided with an educational pack.
Additionally, the company that markets Obizur will provide healthcare professionals who are expected to use Obizur with educational material containing information on how to calculate the dose.
The MAH shall ensure that in each Member State where Atryn is marketed,all healthcare professionals who are expected to prescribe and use Atryn have access to/are provided with the following educational package.
The MAH shall ensure that in each Member State where Scenesse is marketed,all healthcare professionals who are expected to use the product are provided with the following educational package and trained.
The MAH shall ensure that, in each Member State where Jylamvo is marketed,all healthcare professionals who are expected to prescribe or dispense Jylamvo have access to the following educational package.
The MAH shall ensure that in each Member State where Skilarence is marketed,healthcare professionals who are expected to prescribe and dispense Skilarence have access to the following educational package.
The MAH shall ensure that in each Member State where Dengvaxia is marketed,all healthcare professionals who are expected to use Dengvaxia have access to/are provided with the following educational package.
The MAH shall ensure that in each Member State where Obizur is marketed,all healthcare professionals who are expected to prescribe and dispense Obizur have access to/are provided with the following educational package.
The MAH shall ensure that in each Member State where Uptravi is marketed,all healthcare professionals who are expected to prescribe and/or dispense Uptravi are provided with a Prescriber Kit containing the following.